Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

In Medtronic’s case specifically, the EY authors write, the company reported that its ability to predict and modulate supply ...

On October 25, 2025, the United States Court of Appeals for the Ninth Circuit reaffirmed a fundamental protection under the National Labor ...

The best-performing organizations have decision-makers who focus on clarity, accountability and support when implementing ...

Silver Beech Capital delivered 19.5% annualized returns since inception, navigating a market untethered from fundamentals.

In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...

Your kidneys quietly filter your blood all day, balancing fluids, clearing waste, and helping control blood pressure. Yet ...

Supply chains lack the required “high-fidelity” data and capabilities to operate in today’s complex business climate that is ...

Abstract: Databases form an inseparable part of the information systems. They hold the data formed by the data models. Data are operated by the database management system, which takes an interlayer ...

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started ...

For clients, the value of APIs lies not in the API itself but in what it enables, how easy it is to use and integrate, and how consumable is the technology. The platform-based approach can help all ...

This article is sponsored by Centers Health Care. In this Voices interview, Skilled Nursing News sits down with Dr. Matthew ...